Filing Details
- Accession Number:
- 0001209191-13-038069
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-07-26 16:05:59
- Reporting Period:
- 2013-07-24
- Filing Date:
- 2013-07-26
- Accepted Time:
- 2013-07-26 16:05:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1009356 | Salix Pharmaceuticals Ltd | SLXP | Pharmaceutical Preparations (2834) | 943267443 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1314760 | P William Forbes | 8510 Colonnade Center Drive Raleigh NC 27615 | Evp Research&Devel & Cdo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-07-24 | 12,000 | $17.53 | 102,424 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-07-24 | 3,000 | $69.91 | 99,424 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-07-24 | 6,000 | $70.96 | 93,424 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-07-24 | 3,000 | $71.88 | 90,424 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option to Buy Common Stock | Disposition | 2013-07-24 | 12,000 | $0.00 | 12,000 | $17.53 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 19,200 | 2014-12-16 | No | 4 | M | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Option to Buy Common Stock | $17.63 | 2015-06-09 | 6,250 | 6,250 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2015-06-09 | 6,250 | 6,250 | Direct |
Footnotes
- The exercise and sale were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 28, 2013.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.52 to $70.43, inclusive. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.60 to $71.30, inclusive. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.34 to $72.32, inclusive. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- Options are 100% vested.
Billionaire Hedge Funds
